CONMED Corp — Director's Dealing 2021

Sep 17, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2021-09-15

Reporting Person: Hartman Curt R (Director, President, CEO and Chair)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-15	Common Stock	S	2500	$127.387	Disposed	64980	Direct
2021-09-15	Common Stock	M	34000	$39.87	Acquired	98980	Direct
2021-09-15	Common Stock	F	19349	$127.2425	Disposed	79631	Direct
2021-09-15	Common Stock	M	47500	$41.93	Acquired	127131	Direct
2021-09-15	Common Stock	F	28182	$127.28	Disposed	98949	Direct
2021-09-17	Common Stock	G	89000	—	Disposed	9949	Direct
2021-09-17	Common Stock	G	89000	—	Acquired	89000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-15	Options To Purchase Common Stock	$39.87	M	34000	Disposed	2026-03-01	Common Stock (34000)	Direct
2021-09-15	Options To Purchase Common Stock	$41.93	M	47500	Disposed	2027-03-01	Common Stock (47500)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.31 to $127.42. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: This transaction involved a gift of securities by the reporting person to a trust in which the reporting person's spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by the trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the trust's shares for purposes of Section 16 or for any other purpose.

F3: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.